Showing results (11-20 of 225) with videos related to

Sort By:
Pageof 23
Neuro-Oncology Advances|July 10, 2020
Eosinophil and lymphocyte counts predict bevacizumab response and survival in recurrent glioblastomaEugene J Vaios, Sebastian F Winter, Alona Muzikansky, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|December 17, 2013
Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patientsScott R Plotkin, Vanessa L Merker, Alona Muzikansky, et al.
Journal of Neurosurgery|October 15, 2016
Bone marrow response as a potential biomarker of outcomes in glioblastoma patientsEugene J Vaios, Brian V Nahed, Alona Muzikansky, et al.
Scientific Reports|January 13, 2021
Temperature induced changes in the optical properties of skin in vivoTyler W Iorizzo, Peter R Jermain, Elena Salomatina, et al.
Cancers|March 11, 2023
Translational Potential of Fluorescence Polarization for Breast Cancer CytopathologyPeter R Jermain, Dina H Kandil, Alona Muzikansky, et al.
Cancer Research|December 3, 2005
Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive diseaseDavid I Bellovin, Richard C Bates, Alona Muzikansky, et al.
Cancer Chemotherapy and Pharmacology|April 9, 2014
Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patientsKatherine M Slusarz, Vanessa L Merker, Alona Muzikansky, et al.
Pageof 23